Broward Health North Hematology and Medical Oncology

Topics

• CAR-T cell therapy research 66
• Hematopoietic Stem Cell Transplantation 65
• Acute Myeloid Leukemia Research 37
• Lymphoma Diagnosis and Treatment 19
• Multiple Myeloma Research and Treatments 15
• Chronic Myeloid Leukemia Treatments 11
• Acute Lymphoblastic Leukemia research 9
• HIV/AIDS Research and Interventions 7
• Myeloproliferative Neoplasms: Diagnosis and Treatment 7
• Viral-associated cancers and disorders 7
• Cytomegalovirus and herpesvirus research 6
• Antifungal resistance and susceptibility 5

Most cited

1. Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma.

   Blood · 2023 · 409 citations · Lazaros Lekakis

2. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.

   Nature medicine · 2021 · 534 citations · Jay Spiegel

3. Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia.

   The New England journal of medicine · 2024 · 204 citations · Amer Beitinjaneh

4. Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 292 citations · Amer Beitinjaneh

5. Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study.

   The Lancet. Oncology · 2025 · 84 citations · Amer Beitinjaneh

6. Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.

   Blood · 2021 · 295 citations ·